Federica Pericle
Fondateur chez SeneXta Therapeutics SA
Postes actifs de Federica Pericle
Sociétés | Poste | Début | Fin |
---|---|---|---|
Onelife SA
Onelife SA Investment ManagersFinance Onelife SA provides investment advice. The private company is based in Lugano, Switzerland. and has subsidiaries in Luxembourg, Switzerland and Liechtenstein. The Swiss company was founded in 2006 by Enrico Braglia. Enrico Braglia has been the CEO since 2006. | Consultant / Advisor | 01/05/2007 | - |
Analyst-Equity | 01/05/2007 | - | |
Gestionnaire de Portefeuille-Actions | 01/05/2007 | - | |
SeneXta Therapeutics SA
SeneXta Therapeutics SA Medical SpecialtiesHealth Technology SeneXta Therapeutics SA engages in the research and development of therapies for neurodegenerative disorders. The firm provides medicines that maintain healthy brain ageing and rehabilitation after ischemic brain injury. The company was founded by Enrico Braglia and Federica Pericle in 2008 and is headquartered in Lugano, Switzerland. | Directeur des opérations | 18/09/2009 | - |
Fondateur | 18/09/2009 | - |
Historique de carrière de Federica Pericle
Anciens postes connus de Federica Pericle
Sociétés | Poste | Début | Fin |
---|---|---|---|
Agilvax, Inc.
Agilvax, Inc. BiotechnologyHealth Technology Agilvax, Inc. discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases. It optimizes lead immunotherapy candidates through an extensive in vitro and in vivo testing process to ensure clinical efficacy. The company was founded in 2011 and is headquartered in Albuquerque, NM. | Directeur/Membre du Conseil | 01/05/2013 | 25/07/2019 |
Directeur Général | 01/05/2013 | 25/07/2019 | |
President | 01/05/2013 | 25/07/2019 | |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Federica Pericle
University of Turin | Doctorate Degree |
University of South Florida | Graduate Degree |
The University of Texas at Austin | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 5 |
Suisse | 3 |
Italie | 2 |
Opérationnelle
Analyst-Equity | 1 |
Consultant / Advisor | 1 |
Portfolio Manager-Equities | 1 |
Sectorielle
Consumer Services | 4 |
Health Technology | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Onelife SA
Onelife SA Investment ManagersFinance Onelife SA provides investment advice. The private company is based in Lugano, Switzerland. and has subsidiaries in Luxembourg, Switzerland and Liechtenstein. The Swiss company was founded in 2006 by Enrico Braglia. Enrico Braglia has been the CEO since 2006. | Finance |
SeneXta Therapeutics SA
SeneXta Therapeutics SA Medical SpecialtiesHealth Technology SeneXta Therapeutics SA engages in the research and development of therapies for neurodegenerative disorders. The firm provides medicines that maintain healthy brain ageing and rehabilitation after ischemic brain injury. The company was founded by Enrico Braglia and Federica Pericle in 2008 and is headquartered in Lugano, Switzerland. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Agilvax, Inc.
Agilvax, Inc. BiotechnologyHealth Technology Agilvax, Inc. discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases. It optimizes lead immunotherapy candidates through an extensive in vitro and in vivo testing process to ensure clinical efficacy. The company was founded in 2011 and is headquartered in Albuquerque, NM. | Health Technology |
- Bourse
- Insiders
- Federica Pericle
- Expérience